Features May 2018 Issue
Heart Failure Breakthrough
New drug excels at reducing deaths and hospitalizations.
Cardiologists are calling angiotensin receptor/neprilysin inhibitors (ARNIs) one of the most exciting developments in heart failure in decades. These drugs relax blood vessels and eliminate excess fluid and sodium in a new, very effective way.
To continue reading this article you must be a paid subscriber.
Subscribe to Heart Advisor
Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.
With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.
Subscriber Log In
Forgot your password? Click Here.
Already subscribe but haven't registered for all the benefits of the website? Click here.